Browsing by Author Liberopoulos, E. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 96 to 115 of 117 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
A review of the lipid-related effects of fluvastatinLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.; Wierzbicki, A. S.; Elisaf, M. S.24-Nov-2015-
A review of the metabolic effects of sibutramineFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Review: Antiplatelet drugs: what comes next?Kei, A. A.; Florentin, M.; Mikhailidis, D. P.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
The role of C-reactive protein in atherosclerotic cardiovascular disease: an overviewNakou, E. S.; Liberopoulos, E. N.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S.24-Nov-2015-
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Should a statin be prescribed to every patient with heart failure?Tsouli, S. G.; Liberopoulos, E. N.; Goudevenos, J. A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
SIADH and hyponatremia with theophyllineLiberopoulos, E. N.; Alexandridis, G.; Christidis, D. S.; Elisaf, M. S.24-Nov-2015-
Sibutramine-associated adverse effects: a practical guide for its safe useFlorentin, M.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetesFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Statin pleiotropy against renal injuryKostapanos, M. S.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Statin treatment may be beneficial to both the kidneys and the heartAthyros, V. G.; Karagiannis, A.; Liberopoulos, E. N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statin-associated adverse effects beyond muscle and liver toxicityKiortsis, D. N.; Filippatos, T. D.; Mikhailidis, D. P.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Statins and solid organ transplantationGazi, I. F.; Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins for non-alcoholic fatty liver disease: a new indication?Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins: another class of antihypertensive agents?Milionis, H. J.; Liberopoulos, E. N.; Achimastos, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitusMilionis, H. J.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the "treating to new targets" (TNT) trial?Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: Where we are now?Liberopoulos, E. N.; Elisaf, M. S.; Tselepis, A. D.; Archimandritis, A.; Kiskinis, D.; Cokkinos, D.; Mikhailidis, D. P.24-Nov-2015-
Visceral leishmaniasis resembling systemic lupus erythematosusVoulgari, P. V.; Pappas, G. A.; Liberopoulos, E. N.; Elisaf, M. S.; Skopouli, F. N.; Drosos, A. A.24-Nov-2015-